baseline use of hydroxychloroquine in systemic lupus erythematosus does indeed preclude sars-cov-2 infection and severe covid-19
baseline use of hydroxychloroquine in systemic lupus erythematosus does indeed preclude sars-cov-2 infection and severe covid-19
safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study.